Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control

Diabetes mellitus is a major cause of chronic kidney disease and end-stage renal disease. However, the management of chronic kidney disease, particularly diabetes, requires vast improvements. Recently, sodium-glucose cotransporter-2 (SGLT2) inhibitors, originally developed for the treatment of diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Takata, Tomoaki, Isomoto, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122753/
https://www.ncbi.nlm.nih.gov/pubmed/33922132
http://dx.doi.org/10.3390/ijms22094374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122753/
https://www.ncbi.nlm.nih.gov/pubmed/33922132
http://dx.doi.org/10.3390/ijms22094374

Ejemplares similares